# FDA recall D-1382-2014

> **Cubist Pharmaceuticals, Inc.** · Class I · drug recall initiated 2014-04-17.

## Product

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA  02421, NDC 67919-011-01, UPC 3 67919-011-01 6.

## Reason for recall

Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.

## Distribution

Nationwide and Puerto Rico.

## Key facts

- **Recall number:** D-1382-2014
- **Recalling firm:** Cubist Pharmaceuticals, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-04-17
- **Report date:** 2014-06-18
- **Termination date:** 2016-07-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lexington, MA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1382-2014

## Citation

> AI Analytics. FDA recall D-1382-2014. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1382-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*